(-0.05%) 5 097.28 points
(0.13%) 38 288 points
(-0.06%) 15 918 points
(-1.37%) $82.70
(5.93%) $2.04
(0.12%) $2 350.00
(-0.24%) $27.47
(3.78%) $956.95
(-0.20%) $0.933
(-0.31%) $10.99
(-0.51%) $0.796
(1.74%) $93.47
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 4.24%
Live Chart Being Loaded With Signals
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers...
Stats | |
---|---|
Šios dienos apimtis | 517 707 |
Vidutinė apimtis | 1.26M |
Rinkos kapitalizacija | 47.69B |
EPS | $0 ( 2024-01-31 ) |
Kita pelno data | ( $3.65 ) 2024-05-01 |
Last Dividend | $0.510 ( 2024-02-08 ) |
Next Dividend | $0 ( N/A ) |
P/E | 26.04 |
ATR14 | $0.0630 (0.03%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Mauch Robert P. | Buy | 33 877 | Common Stock |
2024-04-15 | Mauch Robert P. | Sell | 57 564 | Common Stock |
2024-04-15 | Mauch Robert P. | Sell | 33 877 | Non-qualified Stock Option (Right to Buy) |
2024-04-16 | Collis Steven H | Buy | 10 754 | Common Stock |
2024-04-16 | Collis Steven H | Sell | 10 754 | Common Stock |
INSIDER POWER |
---|
-94.99 |
Last 100 transactions |
Buy: 2 604 382 | Sell: 9 509 482 |
Tūris Koreliacija
CoreSite Realty Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
AMAM | 0.924 |
ELF | 0.919 |
SLQT | 0.918 |
TDC | 0.915 |
KDMN | 0.915 |
ZGN | 0.909 |
GWW | 0.909 |
CTLT | 0.909 |
MOG-B | 0.907 |
NEWR | 0.904 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
AVYA | -0.957 |
ATTO | -0.955 |
FPI | -0.946 |
KT | -0.945 |
EQC | -0.944 |
GEO | -0.944 |
A | -0.932 |
DHX | -0.931 |
QGEN | -0.93 |
WRBY | -0.925 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
CoreSite Realty Corp Koreliacija - Valiuta/Žaliavos
CoreSite Realty Corp Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $262.17B |
Bruto pelnas: | $8.96B (3.42 %) |
EPS: | $8.62 |
FY | 2023 |
Pajamos: | $262.17B |
Bruto pelnas: | $8.96B (3.42 %) |
EPS: | $8.62 |
FY | 2022 |
Pajamos: | $238.59B |
Bruto pelnas: | $8.33B (3.49 %) |
EPS: | $8.15 |
FY | 2020 |
Pajamos: | $606.82M |
Bruto pelnas: | $412.97M (68.05 %) |
EPS: | $1.960 |
Financial Reports:
No articles found.
CoreSite Realty Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.460 (N/A) |
$0.485 (N/A) |
$0.485 (N/A) |
$0.485 (N/A) |
$0.485 (N/A) |
$0.510 (N/A) |
$0.510 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00625 | 2001-11-15 |
Last Dividend | $0.510 | 2024-02-08 |
Next Dividend | $0 | N/A |
Payout Date | 2024-02-26 | |
Next Payout Date | N/A | |
# dividends | 137 | -- |
Total Paid Out | $51.69 | -- |
Avg. Dividend % Per Year | 2.24% | -- |
Score | 5.48 | -- |
Div. Sustainability Score | 7.90 | |
Div.Growth Potential Score | 5.97 | |
Div. Directional Score | 6.94 | -- |
Year | Amount | Yield |
---|---|---|
2001 | $0.00625 | 0.05% |
2002 | $0.0250 | 0.16% |
2003 | $0.0250 | 0.17% |
2004 | $0.0250 | 0.19% |
2005 | $0.0313 | 0.22% |
2006 | $0.0625 | 0.30% |
2007 | $0.812 | 3.52% |
2008 | $0.163 | 0.73% |
2009 | $0.240 | 1.35% |
2010 | $0.500 | 1.88% |
2011 | $1.060 | 3.09% |
2012 | $1.410 | 3.70% |
2013 | $2.03 | 4.66% |
2014 | $2.47 | 3.53% |
2015 | $3.00 | 3.32% |
2016 | $3.78 | 3.71% |
2017 | $5.06 | 6.12% |
2018 | $5.68 | 6.04% |
2019 | $6.36 | 8.54% |
2020 | $7.81 | 9.18% |
2021 | $6.82 | 7.07% |
2022 | $1.865 | 1.41% |
2023 | $1.965 | 1.20% |
2024 | $0.510 | 0.25% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00687 | 1.500 | 9.86 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0289 | 1.200 | 9.04 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 2.48 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.217 | -1.000 | 7.83 | -7.83 | [0 - 1] |
currentRatioTTM | 0.884 | 0.800 | -0.582 | -0.466 | [1 - 3] |
quickRatioTTM | 0.484 | 0.800 | -1.859 | -1.487 | [0.8 - 2.5] |
cashRatioTTM | 0.0585 | 1.500 | -0.786 | -1.179 | [0.2 - 2] |
debtRatioTTM | 0.0739 | -1.500 | 8.77 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 10.18 | 1.000 | 7.34 | 7.34 | [3 - 30] |
operatingCashFlowPerShareTTM | 20.42 | 2.00 | 3.19 | 6.38 | [0 - 30] |
freeCashFlowPerShareTTM | 18.14 | 2.00 | 0.930 | 1.860 | [0 - 20] |
debtEquityRatioTTM | 5.24 | -1.500 | 10.00 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0330 | 1.000 | -2.78 | -2.78 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.00905 | 1.000 | -1.819 | -1.819 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.855 | 1.000 | 6.36 | 6.36 | [0.2 - 2] |
assetTurnoverTTM | 4.20 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 7.90 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 25.81 | 1.000 | 7.49 | 0 | [1 - 100] |
returnOnEquityTTM | 2.48 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 18.14 | 2.00 | 3.95 | 1.860 | [0 - 30] |
dividendYielPercentageTTM | 0.826 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 20.42 | 2.00 | 3.19 | 6.38 | [0 - 30] |
payoutRatioTTM | 0.217 | 1.500 | 7.83 | -7.83 | [0 - 1] |
pegRatioTTM | 3.19 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0150 | 1.000 | -2.12 | 0 | [0.1 - 0.5] |
Total Score | 5.97 |
CoreSite Realty Corp
Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.